Irisin as a Potential Biomarker Associated with Myocardial Injuries in Patients with Severe Hypothyroidism

Table 3

Cardiovascular magnetic resonance parameters of two subgroups in patients with severe hypothyroidism according to the cutoff value of serum irisin levels.

	Irisin ＜36.94 ng/mL (n = 14)	Irisin ≥36.94 ng/mL (n = 11)	value
Irisin, ng/mL	15.67 ± 3.24	62.73 ± 5.53	≤ 0.001
BSA, m^2	1.70 ± 0.03	1.76 ± 0.05	0.265
EF, %	59.34 ± 2.82	61.11 ± 1.62	0.618
EDV, mL/m^2	55.46 ± 2.22	51.11 ± 1.66	0.159
ESV, mL/m^2	22.89 ± 1.97	19.56 ± 1.19	0.204
SV, mL/m^2	32.57 ± 1.49	31.57 ± 0.98	0.614
CI, l/min/m^2	2.08 ± 0.10	2.27 ± 0.12	0.241
LVMI, g/m^2	49.60 (46.48, 61.05)	54.55 (48.93, 60.75)	0.380
PET, ms	153.19 ± 7.31	149.90 ± 10.87	0.799
PFT, ms	159.09 ± 13.07	157.21 ± 15.43	0.926
Per, EDV/s	3.25 (2.95, 4.15)	3.30 (3.30, 3.60)	0.848
PFR, EDV/s	3.35 (2.75, 3.85)	3.50 (3.00, 4.10)	0.478
Native T1 value, ms	1232.91 ± 21.06	1142.09 ± 23.22	0.008

Data are expressed as mean ± SME or median (interquartile range) unless stated otherwise. .